Oxaliplatin and neuropathy: A role for sodium channels

Ensuring long-term quality of life in cancer survivors following treatment is critically important, particularly given the increasing effectiveness of treatments. Chemotherapy-induced peripheral neuropathy (CIPN) remains a major side effect of cancer therapy, with many commonly used chemotherapies, leading to early cessation and long-lasting disability (Park et al., 2013).

Source: Clinical Neurophysiology - December 28, 2017 Category: Neuroscience Authors: Susanna B. Park, Matthew C. Kiernan Tags: Editorial Source Type: research